Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168919 · ClinicalTrials.gov registry record · NA
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03168919: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.
NCT03168919 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168919, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The overall goal of this study is to determine if quantitative imaging techniques can be used to detect dynamic changes of morphology and different physiologic properties of the tumor during and after completion of radiation treatment and to predict site and time of radiation.
Primary Outcome
Multiple MRI techniques will be used to assess chemical environment (Cho/NAA) of the tumor during the course of fractionated radiation treatment.
Interventions
- DRUG Temozolomide
- DEVICE MRI
- RADIATION Fractionated Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-10-06 |
| Est. Completion | 2018-06-12 |
| Phase | NA |
Why NCT03168919 stopped before completion
NCT03168919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Temozolomide is the first listed.
NCT03168919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03168919 about?
NCT03168919 is a clinical study titled "Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma". The overall goal of this study is to determine if quantitative imaging techniques can be used to detect dynamic changes of morphology and different physiologic properties of the tumor during and after completion of radiation treatment and to predict site and time of radiation.
What is the current status of trial NCT03168919?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2016-10-06. Estimated completion is 2018-06-12.
What interventions are being tested in trial NCT03168919?
The interventions under investigation include: Temozolomide (DRUG), MRI (DEVICE), Fractionated Radiation (RADIATION).
Who is sponsoring clinical trial NCT03168919?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03168919's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI